# Perimeter Medical Imaging AI

Claire 是首个获 FDA 批准的、用于乳腺癌手术切缘评估的 AI 赋能光学相干断层扫描（OCT）成像设备，在不破坏组织的情况下扫描切除标本表面。

Source: https://cn.bioecon.ru/companies/perimeter-medical-imaging-ai/
Updated: 2026-07-20

- 国家: Canada

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | 通过Life Offering募集7,521,150加元（2026年5月完成）及通过可转换债券募集6,040,000加元（2026年6月完成） | https://ca.marketscreener.com/news/perimeter-medical-imaging-ai-inc-reports-earnings-results-for-the-second-quarter-and-six-months-en-ce7858d9d08cff22, https://www.prnewswire.com/news-releases/perimeter-announces-preliminary-second-quarter-2026-financial-results-302856831.html |
| 员工人数 | 截至2026年4月3日约有38名员工和3名独立承包商 | https://newsfile.futunn.com/public/NN-PersistNoticeAttachment/7781/20260403/SEDAR_PLUS/CSA_SEDAR_PLUS_NOTICE_RECORD_ID_2371965.pdf |
| 营收 | 2026年第二季度为$503,000;2026年第一季度为$385,000;2025全年为$230万 | https://www.prnewswire.com/news-releases/perimeter-announces-preliminary-second-quarter-2026-financial-results-302856831.html |
| 监管批准 | Claire 系统于2026年3月3日获得 FDA 上市前批准（PMA） | https://ir.perimetermed.com/news-events/press-releases/detail/200/perimeter-medical-imaging-ais-claire-becomes-first, https://newsfile.futunn.com/public/NN-PersistNoticeAttachment/7781/20260403/SEDAR_PLUS/CSA_SEDAR_PLUS_NOTICE_RECORD_ID_2371965.pdf, https://www.medicaldevice-network.com/projects/claire-oct-system-us/ |
| 认证 | 质量体系遵循ISO 13485:2016和21 CFR 820标准 | https://newsfile.futunn.com/public/NN-PersistNoticeAttachment/7781/20260403/SEDAR_PLUS/CSA_SEDAR_PLUS_NOTICE_RECORD_ID_2371965.pdf |

独立来源: ca.marketscreener.com, ir.perimetermed.com, medicaldevice-network.com, newsfile.futunn.com, prnewswire.com

## 技术

- [术中分子诊断](https://cn.bioecon.ru/technology/intraoperative-molecular-diagnostics/)